奈米技術藥物傳輸市場：按技術、按應用、按最終用戶、按地區

全球奈米技術藥物輸送市場預計到2024年將達到971億美元，預計到2031年將達到2032.1億美元，2024年至2031年的複合年成長率為11.1%。

圖：2024 年按地區分類的奈米技術藥物輸送市場佔有率(%)

基於奈米技術的藥物傳輸解決了藥物研究和開發中的許多挑戰。透過促進治療標靶化和控制遞送，奈米技術提高了藥物有效負載的溶解度、穩定性和生物有效性。人們已經研究了各種奈米載體，包括脂質體、聚合物奈米顆粒、無機奈米顆粒和樹狀聚合物，它們封裝藥物分子並將其有效轉運至體內目標位點的能力。材料工程和表面功能化方面正在進行的研究可以最佳化這些奈米載體，以實現最佳的藥物動力學和生物分佈曲線。全球奈米技術藥物傳輸市場可能會成長，因為該領域將尖端研究轉化為安全有效的醫療解決方案。

市場動態：

全球奈米技術藥物輸送市場的成長是由奈米載體克服傳統藥物傳遞的許多限制的能力所推動的。奈米載體可以增加難溶性藥物的溶解度並保護治療有效負載不被分解，從而提高生物有效性。由於滲透性和保留性增強，奈米載體的小尺寸允許被動靶向腫瘤部位。使用表面配體的主動靶向可以幫助將高濃度的藥物特異性輸送到患病細胞，同時避免對健康組織的毒性。然而，奈米載體設計的複雜性、高研究成本以及有關長期安全性和毒性評估的監管挑戰等因素可能會阻礙市場成長。多功能奈米載體的採用和持續的材料最佳化可能會提供新的機會來開發針對以前無法治療的標靶的治療方法並將應用擴展到新的疾病領域。

本研究的主要特點

• 該報告對全球奈米技術藥物輸送市場進行了詳細分析，並以2023年為基準年估計了預測期內（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。發表。
• 它揭示了各個細分市場的潛在商機，並說明了該市場中有吸引力的投資提案的矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
• 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球奈米技術藥物輸送市場的主要企業。
• 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
• 全球奈米技術藥物輸送市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員可以透過用於全球奈米技術藥物傳輸市場分析的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

• 研究目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• 一致的機會地圖 (COM)

第3章 市場動態、法規與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管場景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章全球奈米技術藥物傳輸市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第5章 全球奈米科技藥物輸送市場，依科技分類，2019-2031 年（十億美元）

• 介紹
• 奈米粒子
• 奈米懸浮液
• 脂質體
• 膠束
• 其他

第6章 2019-2031 年全球奈米技術藥物傳輸市場（按應用分類）（十億美元）

• 介紹
• 腫瘤學和血液學
• 感染疾病
• 整形外科
• 神經病學
• 泌尿系統
• 免疫學
• 其他

第7章 全球奈米科技藥物輸送市場，依最終用戶分類，2019-2031 年（十億美元）

• 介紹
• 醫院/診所
• 生物製藥公司
• 研究機構/研究所
• 其他

第8章全球奈米技術藥物傳輸市場，按地區，2019-2031（十億美元）

• 介紹
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東

第9章 競爭格局

• 公司簡介
  • AbbVie Inc.
  • Geistlich Pharma AG
  • Alkermes plc
  • Amgen Inc.
  • AngioDynamics Inc.
  • Arrowhead Pharmaceuticals Inc.
  • BIND Therapeutics Inc.
  • Capsulution Nanoscience AG
  • Celgene Corporation
  • Johnson &Johnson
  • Nanobiotix
  • Nanocarrier Co. Ltd.
  • Merck &Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • SkyePharma PLC
  • Starpharma Holdings Limited
  • Teva Pharmaceutical Industries Ltd.

第10章分析師建議

• 上升和下降
• 綜合機會圖

第11章 參考文獻與調查方法

• 參考
• 調查方法

Global nanotechnology drug delivery market is estimated to be valued at USD 97.10 Bn in 2024 and is expected to reach USD 203.21 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031.

Figure. Nanotechnology Drug Delivery Market Share (%), By Region 2024

Nanotechnology-based drug delivery address many challenges in pharmaceutical research and development. By facilitating targeted and controlled delivery of therapeutic agents, nanotechnology improves the solubility, stability and bioavailability of drug payloads. Various nanocarriers such as liposomes, polymeric nanoparticles, inorganic nanoparticles and dendrimers are being investigated for their ability to encapsulate drug molecules and transport them efficiently to target sites in the body. Ongoing research in material engineering and surface functionalization can optimize these nanocarriers for achieving optimal pharmacokinetic and biodistribution profiles. Global nanotechnology drug delivery market can witness growth as this field translates cutting-edge research into safe and effective medical solutions.

Market Dynamics:

Global nanotechnology drug delivery market growth is driven by the ability of nanocarriers to overcome many limitations of conventional drug delivery. Nanocarriers can enhance solubility of poorly soluble drugs and protect therapeutic payloads from degradation, thus, improving bioavailability. Their small size enables achievement of passive targeting to tumor sites via enhanced permeability and retention effect. Active targeting using surface ligands helps to deliver high drug concentrations specifically to diseased cells while avoiding toxicity to healthy tissues. However, factors such as complexity of nanocarrier design, high research costs, and regulatory challenges related to long-term safety and toxicity assessment can hamper the market growth. The introduction of multifunctional nanocarriers and continuing material optimization can offer new opportunities to develop therapeutics for previously undruggable targets and expand applications to newer disease areas.

Key features of the study:

• This report provides in-depth analysis of the global nanotechnology drug delivery market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global nanotechnology drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer, Johnson & Johnson, AbbVie, Novartis, and Amgen
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global nanotechnology drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nanotechnology drug delivery market

Detailed Segmentation-

• By Technology
  • Nanoparticles
  • Nano suspensions
  • Liposomes
  • Micelles
  • Others
• By Application
  • Oncology and Hematology
  • Infectious diseases
  • Orthopedics
  • Neurology
  • Urology
  • Immunology
  • Others
• By End User
  • Hospitals & Clinics
  • Biopharmaceutical Companies
  • Research Institutes & Laboratories
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AbbVie Inc.
  • Geistlich Pharma AG
  • Alkermes plc
  • Amgen Inc.
  • AngioDynamics Inc.
  • Arrowhead Pharmaceuticals Inc.
  • BIND Therapeutics Inc.
  • Capsulution Nanoscience AG
  • Celgene Corporation
  • Johnson & Johnson
  • Nanobiotix
  • Nanocarrier Co. Ltd.
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • SkyePharma PLC
  • Starpharma Holdings Limited
  • Teva Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Nanotechnology Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Nanotechnology Drug Delivery Market, By Technology, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Nanoparticles
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Nano suspensions
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Liposomes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Micelles
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Nanotechnology Drug Delivery Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oncology and Hematology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Infectious diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Orthopedics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Neurology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Urology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Immunology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Nanotechnology Drug Delivery Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Biopharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Institutes & Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Nanotechnology Drug Delivery Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Geistlich Pharma AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alkermes plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AngioDynamics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Arrowhead Pharmaceuticals Inc.
  • BIND Therapeutics Inc.
  • Capsulution Nanoscience AG
  • Celgene Corporation
  • Johnson & Johnson
  • Nanobiotix
  • Nanocarrier Co. Ltd.
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • SkyePharma PLC
  • Starpharma Holdings Limited
  • Teva Pharmaceutical Industries Ltd.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Reference and Research Methodology

• References
• Research Methodology
• About us and Sales Contact